Kiat Ruxrungtham

Kiat Ruxrungtham

As Founder and Co-Director of Chula VRC, Kiat Ruxrungtham conducts vaccine research work and gathering professors and researchers interested in the research and development of vaccines into Center of Excellence in Vaccine Research and Development. He spent more than 30 years exploring HIV treatment strategies, HIV T cell immunology, vaccine development (including dengue, HIV and house dust mite (HDM) vaccine); and strategies to improve DNA vaccine immunogenicity. He has supervised and lead Chula VRC’s effect to rapidly advance the promising HDM vaccine candidates from the lab bench to clinical trial.

Ruxrungtham holds a Professor of Medicine from Department of Medicine, Chulalongkorn University. He is providing teaching and patient care at the King Chulalongkorn Memorial Hospital, and is mentoring junior researchers on vaccine, immunology research and also on clinical trials. He currently is a vice president for research and innovation, Chulalongkorn University.

He has published more than 230 peer review papers on HIV, immunology and allergy. He is a faculty member of the faculty 1000 of Medicine, a chief editor of Asia Pacific J of Allergy and editorial board member of Immunology, ImmunoTargets and Therapy, Asian Biomedicine, and the Scientific Report. He is also a reviewer for > 9 journals.

positions: Founder and Co-Director
degree: M.D.